Quest Diagnostics
DGX
#1122
Rank
โ‚น1.916 T
Marketcap
โ‚น17,140
Share price
2.57%
Change (1 day)
21.63%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Earnings for Quest Diagnostics (DGX)

Earnings in 2025 (TTM): โ‚น111.29 Billion

According to Quest Diagnostics 's latest financial reports the company's current earnings are โ‚น10.85 Billion. In 2024 the company made an earning of โ‚น107.67 Billion, an increase over its 2023 earnings that were of โ‚น103.55 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quest Diagnostics from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น111.29 B3.36%
2024 โ‚น107.67 B3.98%
2023 โ‚น103.55 B-8.5%
2022 โ‚น113.17 B-52.48%
2021 โ‚น238.17 B37.95%
2020 โ‚น172.65 B75.09%
2019 โ‚น98.60 B16.2%
2018 โ‚น84.85 B-10.1%
2017 โ‚น94.39 B-5.16%
2016 โ‚น99.52 B-1.54%
2015 โ‚น101.08 B31%
2014 โ‚น77.16 B-37.52%
2013 โ‚น123.50 B26.93%
2012 โ‚น97.30 B24.01%
2011 โ‚น78.46 B-27.7%
2010 โ‚น108.53 B-3.55%
2009 โ‚น112.52 B19.59%
2008 โ‚น94.09 B12.54%
2007 โ‚น83.61 B-11.7%
2006 โ‚น94.69 B13.49%
2005 โ‚น83.43 B9.02%
2004 โ‚น76.53 B13.19%
2003 โ‚น67.61 B36.03%
2002 โ‚น49.70 B63.07%
2001 โ‚น30.48 B65.49%
2000 โ‚น18.41 B1297.84%
1999 โ‚น1.31 B-73.37%
1998 โ‚น4.94 B-384.21%
1997 -โ‚น1.75 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
LabCorp
LH
โ‚น122.17 B 3.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น3.81 B-96.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น0.18 Billion-100.15%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น10.01 Billion-108.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น49.59 B-57.95%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น0.72 Billion-100.61%๐Ÿ‡บ๐Ÿ‡ธ USA